Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-((3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)phenoxy)methyl)-4-(3-chlorophenyl)-2-oxido(1,3,2)dioxaphosphonane
2. Mb 07811
3. Mb-07811
4. Mb07811
5. Vk2809
1. Mb-07811
2. 852948-13-1
3. Mb07811
4. Vk-2809
5. Vk2809
6. Unii-3z11398fnq
7. Chembl457748
8. 3z11398fnq
9. Mb-07811 (vk-2809)
10. 4-[[4-[[(2r,4s)-4-(3-chlorophenyl)-2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl]methoxy]-2,6-dimethylphenyl]methyl]-2-propan-2-ylphenol
11. (2r,4s)-4-(3-chlorophenyl)-2-((4-(4-hydroxy-3-isopropylbenzyl)-3,5-dimethylphenoxy)methyl)-1,3,2-dioxaphosphinane 2-oxide
12. Mb 07811
13. Schembl282796
14. Gtpl12768
15. Dtxsid501005783
16. Ex-a3394
17. Bdbm50401076
18. Akos040742104
19. Db15137
20. Compound 22c [pmid: 18975928]
21. Trans-(s)-2-((3,5-dimethyl-4-(4-hydroxy-3-isopropylbenzyl)phenoxy)methyl)-4-(3-chlorophenyl)-2-oxo-(1,3,2)dioxaphosphorinane
22. Hy-111288
23. Cs-0034844
24. Q27258223
25. (2r,4s)-4-(3-chlorophenyl)-2-((3,5-dimethyl-4-(4-hydroxy-3-isopropylbenzyl)phenoxy)methyl)-2-oxido-(1,3,2)-dioxaphosphonane
26. 2-((3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)phenoxy)methyl)-4-(3-chlorophenyl)-2-oxido(1,3,2)dioxaphosphonane
27. 4-(3-chlorophenyl)-2-[(4-{[4-hydroxy-3-(propan-2-yl)phenyl]methyl}-3,5-dimethylphenoxy)methyl]-1,3,2lambda~5~-dioxaphosphinan-2-one
| Molecular Weight | 515.0 g/mol |
|---|---|
| Molecular Formula | C28H32ClO5P |
| XLogP3 | 6.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 65 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 708 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in hyperlipidemia.
Studies indicate that targeting TR agonists to the liver has the potential to lower both LDL-cholesterol (the "bad" cholesterol) and both hepatic and plasma triglyceride levels.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
74
PharmaCompass offers a list of VK2809 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right VK2809 manufacturer or VK2809 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred VK2809 manufacturer or VK2809 supplier.
PharmaCompass also assists you with knowing the VK2809 API Price utilized in the formulation of products. VK2809 API Price is not always fixed or binding as the VK2809 Price is obtained through a variety of data sources. The VK2809 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 852948-13-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 852948-13-1, including repackagers and relabelers. The FDA regulates 852948-13-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 852948-13-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 852948-13-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 852948-13-1 supplier is an individual or a company that provides 852948-13-1 active pharmaceutical ingredient (API) or 852948-13-1 finished formulations upon request. The 852948-13-1 suppliers may include 852948-13-1 API manufacturers, exporters, distributors and traders.
click here to find a list of 852948-13-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
852948-13-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 852948-13-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 852948-13-1 GMP manufacturer or 852948-13-1 GMP API supplier for your needs.
A 852948-13-1 CoA (Certificate of Analysis) is a formal document that attests to 852948-13-1's compliance with 852948-13-1 specifications and serves as a tool for batch-level quality control.
852948-13-1 CoA mostly includes findings from lab analyses of a specific batch. For each 852948-13-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
852948-13-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (852948-13-1 EP), 852948-13-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (852948-13-1 USP).
